Abstract:Background: Functional drug testing (FDT) with patient-derived tumor cells in microfluidic devices is gaining popularity. However, the majority of previously reported microfluidic devices for FDT were limited by at least one of these factors: lengthy fabrication procedures, absence of tumor progenitor cells, lack of clinical correlation, and mono-drug therapy testing. Furthermore, personalized microfluidic models based on spheroids derived from oral cancer patients remain to be thoroughly validated. Overcoming the limitations, we develop 3D printed mold-based, dynamic, and personalized oral stem-like spheroids-on-a-chip, featuring unique serpentine loops and flat-bottom microwells arrangement. Results: This unique arrangement enables the screening of seven combinations of three drugs on chemoresistive cancer stem-like cells. Oral cancer patients-derived stem-like spheroids (CD 44+) remains highly viable (> 90%) for 5 days. Treatment with a well-known oral cancer chemotherapy regimen (paclitaxel, 5 fluorouracil, and cisplatin) at clinically relevant dosages results in heterogeneous drug responses in spheroids. These spheroids are derived from three oral cancer patients, each diagnosed with either well-differentiated or moderately-differentiated squamous cell carcinoma. Oral spheroids exhibit dissimilar morphology, size, and oral tumor-relevant oxygen levels (< 5% O2). These features correlate with the drug responses and clinical diagnosis from each patient's histopathological report. Conclusions: Overall, we demonstrate the influence of tumor differentiation status on treatment responses, which has been rarely carried out in the previous reports. To the best of our knowledge, this is the first report demonstrating extensive work on development of microfluidic based oral cancer spheroid model for personalized combinatorial drug screening. Furthermore, the obtained clinical correlation of drug screening data represents a significant advancement over previously reported personalized spheroid-based microfluidic devices. Finally, the maintenance of patient-derived spheroids with high viability under oral cancer relevant oxygen levels of less than 5% O2 is a more realistic representation of solid tumor microenvironment in our developed device.

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Drug screening on digital microfluidics for cancer precision medicine

Drug Screening Of Cancer Cell Lines And Human Primary Tumors Using Droplet Microfluidics (Vol 7, 9109, 2017)

Application of a Microfluidic Chip-Based 3D Co-Culture to Test Drug Sensitivity for Individualized Treatment of Lung Cancer.

Drug effects analysis on cells using a high throughput microfluidic chip

High throughput analysis of drug effects on single breast cancer cells using droplet-microfluidic devices

A Microfluidic Digital Single-Cell Assay for the Evaluation of Anticancer Drugs.

From Chips-in-Lab to Point-of-Care Live Cell Device: Development of a Microfluidic Device for On-Site Cell Culture and High-Throughput Drug Screening

Drug testing of monodisperse arrays of live microdissected tumors using a valved multiwell microfluidic platform

Selectively cross-linked hydrogel-based cocktail drug delivery micro-chip for colon cancer combinatorial drug screening using AI-CSR platform for precision medicine

Anti-Cancer Drug Screening with Microfluidic Technology

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Application of microfluidic chips in anticancer drug screening

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation

A UV-sensitive Hydrogel Based Combinatory Drug Delivery Chip (UV Gel-Drug Chip) for Cancer Cocktail Drug Screening

Cancer drug screening with an on-chip multi-drug dispenser in digital microfluidics

High-throughput and Label-Free Enrichment of Malignant Tumor Cells and Clusters from Pleural and Peritoneal Effusions Using Inertial Microfluidics.